| SPS Home | Contact Us |
  General Information  Registration & Housing   Scientific Programs   Ancillary Presentations   Exhibitors & Sponsors   Awards  


SPS 2009 Sponsors

Diamond
($15,000+)

Charles River

Pfizer, Inc.

Emerald
($10,000 to $14,999)

Pfizer, Inc.

Ruby
($6,000 to $9,999)

Chantest

Hoffman-La Roche

Opal
($3,000 to $5,999)

AMGEN

AstraZeneca

Boehringer Ingelheim

Elsevier

GlaxoSmithKline

Eli Lilly and Company

MDS Pharma Services

MPI Research

PhysioStim

Porsolt and Partners Pharmacology

sanofi-aventis

Schering-Plough

Sapphire
(Up to $2,999)

Abbott

Aptuit

Calvert Laboratories

Data Sciences International

ITR Labs

Lewis B. Kinter & Terry Timberlake-Kinter

LAB Research Inc.

Wil Research

Xenometrics


The Distinguished Service Award Deadline is extended to January 30, 2009.   Please submit your nominations to SPS Headquarters!  We request that you make nominations now for this coveted award to honor your fellow safety pharmacologist.  We have modified the nomination process to simplify the initial application.  Please see the amended details below.   The Distinguished Service Award Committee is anxiously awaiting the nominations for this year.  Your help and support with this nomination process is greatly appreciated.

Warn regards,
JoAnne Saye, Co-chair
Alan Bass, Co-chair

Nominations close at midnight EDT January 30, 2009

To download an application please click here: Distinguished Service Award Nomination Application

This award is to honor an individual who has substantially contributed to the field of Safety Pharmacology.

For a nomination, the following criteria will be considered:

Specific research achievements
Champions of the field
Lifelong contribution to the field
Substantial specific contribution
Visionary direction
Regulatory decisions
Science of the field
Education
Collaboration between industry and academia

The Distinguished Service Award (DSA) will be given every year, although there shall be no obligation or duty to make such award when, in the sole opinion of the committee, there is no qualified nominee.

Nominations
Only Members may nominate although the nominee does not have to be a member. A member may not nominate more than one person per year.

Nominations must contain name of nominee, current position and address, and current e-mail address with the completed application (see above).    After the nominations are received, the DSA committee will consider the nominees and generate a short list of nominees.   At this time the committee will solicit from the nominators of the individuals from the short list three letters of support, a current Curriculum Vitae, and supporting documentation that indicates the nominee's achievements in safety pharmacology (critical in the review of each nominee). Electronic (Word or PDF) or Faxed copy of the nomination should be sent to SPS Headquarters.

The Award
Presentation of the Award will be given at the Annual Meeting of the Society. The recipient will be given a plaque, a cash award, and an invitation to deliver a presentation that may be published with the meeting proceedings. Travel expenses for the recipient to attend the meeting will be paid.

The DSA Committee
The President will, in January, appoint a committee of 4, and either Chairs the committee or appoints a chair, making a five-person committee.
  
Nominations are due by January 30, 2009. The Committee will review the nominations, have a teleconferences in February, request additional information as needed and make a decision by February 27, 2009. The winner will be notified no later than March 2009 by letter from the President and/or the Chair of the Committee.